| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophysical Journal 56: 749-756 (1989)
© 1989 the Biophysical Society
Departamento de Fisiología y Biofísica, Universidad de Chile.
ABSTRACT
Sarcoplasmic reticulum vesicles isolated from fast-twitch frog skeletal muscle presented two classes of binding sites for ryanodine, one of high affinity (Kd1 = 1.7 nM, Bmax1 = 3.3 pmol per mg) and a second class with lower affinity (Kd2 = 90 nM, Bmax2 = 7.0 pmol per milligram). The calcium channels present in the sarcoplasmic reticulum membranes were studied in vesicles fused into lipid bilayers. Low concentrations of ryanodine (5 to 10 nM) activated a large conductance calcium channel after a short delay (5 to 10 min). The activation, which could be elicited from conditions of high or low fractional open time, was characterized by an increase in channel fractional open time without a change in conductance. The open and closed dwell time distributions were fitted with the sum of two exponentials in the range of 4 to 800 ms. The activating effect of ryanodine was due to an increase of both open time constants and a concomitant decrease in the closed time constants. Under conditions of low fractional open time (less than 0.1), the time spent in long closed periods (greater than 800 ms) between bursts was not affected by ryanodine. Higher concentrations of ryanodine (250 nM) locked the channel in a lower conductance level (approximately 40%) with a fractional open time near unity. These results suggest that the activating effects of nanomolar concentrations of ryanodine may arise from drug binding to high affinity sites. The expression of the lower conductance state obtained with higher concentrations of ryanodine may be associated with the low affinity binding sites observed in frog sarcoplasmic reticulum.
This article has been cited by other articles:
![]() |
R. Bull, J. P. Finkelstein, J. Galvez, G. Sanchez, P. Donoso, M. I. Behrens, and C. Hidalgo Ischemia Enhances Activation by Ca2+ and Redox Modification of Ryanodine Receptor Channels from Rat Brain Cortex J. Neurosci., September 17, 2008; 28(38): 9463 - 9472. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Sobie, L.-S. Song, and W. J. Lederer Local recovery of Ca2+ release in rat ventricular myocytes J. Physiol., June 1, 2005; 565(2): 441 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lioudyno, H. Hiel, J.-H. Kong, E. Katz, E. Waldman, S. Parameshwaran-Iyer, E. Glowatzki, and P. A. Fuchs A "Synaptoplasmic Cistern" Mediates Rapid Inhibition of Cochlear Hair Cells J. Neurosci., December 8, 2004; 24(49): 11160 - 11164. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Hui, H. R. Besch Jr., and K. R. Bidasee Effects of Ryanoids on Spontaneous and Depolarization-Evoked Calcium Release Events in Frog Muscle Biophys. J., July 1, 2004; 87(1): 243 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Aracena, G. Sanchez, P. Donoso, S. L. Hamilton, and C. Hidalgo S-Glutathionylation Decreases Mg2+ Inhibition and S-Nitrosylation Enhances Ca2+ Activation of RyR1 Channels J. Biol. Chem., October 31, 2003; 278(44): 42927 - 42935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Bidasee, L. Xu, G. Meissner, and H. R. Besch Jr. Diketopyridylryanodine Has Three Concentration-dependent Effects on the Cardiac Calcium-release Channel/Ryanodine Receptor J. Biol. Chem., April 11, 2003; 278(16): 14237 - 14248. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Sanchez, C. Hidalgo, and P. Donoso Kinetic Studies of Calcium-Induced Calcium Release in Cardiac Sarcoplasmic Reticulum Vesicles Biophys. J., April 1, 2003; 84(4): 2319 - 2330. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. DiJulio, E. L. Watson, I. N. Pessah, K. L. Jacobson, S. M. Ott, E. D. Buck, and J. C. Singh Ryanodine Receptor Type III (Ry3R) Identification In Mouse Parotid Acini. PROPERTIES AND MODULATION OF [3H]RYANODINE-BINDING SITES J. Biol. Chem., June 20, 1997; 272(25): 15687 - 15696. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Zucchi and S. Ronca-Testoni The Sarcoplasmic Reticulum Ca2+ Channel/Ryanodine Receptor: Modulation by Endogenous Effectors, Drugs and Disease States Pharmacol. Rev., March 1, 1997; 49(1): 1 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sierralta, M. Fill, and B. A. Suarez-Isla Functionally Heterogenous Ryanodine Receptors in Avian Cerebellum J. Biol. Chem., July 19, 1996; 271(29): 17028 - 17034. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. El-Hayek, A. J. Lokuta, C. Arévalo, and H. H. Valdivia Peptide Probe of Ryanodine Receptor Function J. Biol. Chem., December 1, 1995; 270(48): 28696 - 28704. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dode, K. Van Baelen, F. Wuytack, and W. L. Dean Low Temperature Molecular Adaptation of the Skeletal Muscle Sarco(endo)plasmic Reticulum Ca2+-ATPase 1 (SERCA 1) in the Wood Frog (Rana sylvatica) J. Biol. Chem., February 2, 2001; 276(6): 3911 - 3919. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |